You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 29, 2025

Profile for Argentina Patent: 122784


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 122784

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 21, 2038 Amgen Inc LUMAKRAS sotorasib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent AR122784: Scope, Claims, and Patent Landscape in Argentina

Last updated: August 7, 2025


Introduction

Patent AR122784 pertains to a pharmaceutical invention filed and granted within Argentina. Analyzing its scope, claims, and the broader patent landscape offers insights into its strategic importance, potential competitive barriers, and innovation footprint within the country and possibly beyond. This report provides a comprehensive assessment of these aspects, equipped with legal and market context relevant to pharmaceutical patenting.


1. Patent Overview

Patent Number: AR122784
Filing Date: [Insert specific date if known]
Grant Date: [Insert date]
Applicant: [Insert applicant details]
Inventors: [Insert inventor names]
Legal Status: Granted; enforceable within Argentina

Nature of the Invention:
The patent relates to a novel pharmaceutical compound/formulation/method, potentially targeting specific medical indications. Its scope likely encompasses chemical composition, manufacturing processes, and therapeutic applications, as is typical in pharmaceutical patents.


2. Scope of the Patent

Legal Doctrine:
Argentine patent law adheres to the TRIPS Agreement standards, emphasizing the protection of new, inventive, and industrially applicable inventions. The scope of AR122784 is primarily defined through its claims, which delineate the boundaries of protection.

Scope Analysis:

  • Chemical Composition or Compound: If the patent claims a new chemical entity, it covers a defined molecular structure, including its derivatives and salts.
  • Formulation or Process: The patent might extend to specific formulations, delivery mechanisms, or synthesis methods that enhance stability, bioavailability, or reduce side effects.
  • Therapeutic Use: Claims could include specific medical indications, dosage methods, or treatment protocols employing the compound.

Key Considerations:

  • Argentine patents often encompass multiple claim types, including product claims, process claims, and use claims, which collectively extend the patent's reach.
  • The scope's breadth can influence its enforceability and potential for licensing or litigation.

3. Analysis of the Claims

While the precise language of AR122784's claims cannot be provided without access to the official patent document, typical claims in pharmaceutical patents follow a structured hierarchy:

(a) Independent Claims:

  • Define the core invention, e.g., a chemical compound with specific structural features.
  • Could describe a pharmaceutical composition comprising the compound.
  • May include methods of synthesis or therapeutic use.

(b) Dependent Claims:

  • Specify particular embodiments, such as specific salts, polymorphs, dosage forms, or treatment protocols.
  • Serve to narrow the scope and provide fallback positions during patent enforcement.

Claim Drafting Strategies:

  • Broad claims aim to cover a wide class of compounds or uses, maximizing legal protection.
  • Narrow claims focus on specific compounds or methods, reducing the risk of invalidation.

Implication for Patent Holders:

  • A well-structured set of claims balances breadth with novelty, aiding in deterring infringement while minimizing legal vulnerabilities.

4. Patent Landscape for Pharmaceuticals in Argentina

Legal and Market Context:

  • Argentina upholds TRIPS-compliant patent protections, but pharmaceutical patents face specific challenges, including compulsory licensing and exceptions for public health under Law 24,570.
  • Patent term is generally 20 years from the filing date, but delays may occur due to administrative or regulatory processes.

Active Patent Landscape:

  • Argentina hosts a robust portfolio of patents in the pharmaceutical sector, especially for antimicrobials, cancer treatments, and vaccines.
  • Foreign patent filings are common, with major international pharmaceutical companies actively filing in Argentina to secure regional rights.

Competitive Positioning:

  • Patent AR122784's strategic value depends on its uniqueness, remaining validity period, and infringement landscape.
  • The patent's strength influences its capacity to block generic entry, negotiate licensing, or support regional patent extensions.

Patent Litigation Trends:

  • Argentina has experienced notable patent disputes, especially concerning secondary patents and data exclusivity.
  • The scope and claims of AR122784 will be scrutinized if challenged or during licensing negotiations.

5. Patent Terms and Maintenance

  • Expiration: Typically 20 years from the filing date, subject to maintenance fees.
  • Patent Term Adjustments: Regulatory delays or supplementary protection certificates (SPCs) may extend exclusivity in certain cases, although SPCs are not widely recognized in Argentina.
  • Maintenance: Failure to pay renewal fees can result in lapse.

6. Strategic Implications

  • Innovation Barrier: If AR122784 claims a broad chemical entity or therapeutically significant use, it serves as a strong barrier to entry.

  • Patent Knockout or Amendment: Competitors may attempt to design around the patent by modifying the compound or method claims.

  • Regulatory Considerations: Patent enforceability can be affected by Argentine patent law’s exceptions pertaining to public health.

  • Market Entry & Licensing: The patent's enforceability and scope influence whether license negotiations or generic entry are viable options.


7. Conclusion

Patent AR122784 encapsulates an important spatial jurisdictional claim within Argentina's pharmaceutical patent landscape. Its scope, driven by the drafting of its claims, shapes not only the patent's legal strength but also strategic market positioning. Understanding its detailed claims is essential for assessing infringement risks, licensing potential, and freedom-to-operate considerations. Its position within Argentina’s evolving patent landscape underscores the importance of comprehensive patent management strategies, especially given the country's public health laws and market dynamics.


Key Takeaways

  • Claim Breadth Defines Legal Protection: A broad claim set offers extensive coverage but risks invalidation; narrow claims provide limited protection but are easier to defend.
  • Strategic Patent Positioning: AR122784’s strength depends on its claim novelty, inventive step, and how it complements or overlaps with existing patents.
  • Regulatory and Legal Context: Argentine patent law’s exceptions and the public health law could impact patent enforcement, especially for pharmaceuticals.
  • Patent Lifecycle Management: Timely maintenance and monitoring of patent validity are vital to sustaining exclusive rights.
  • Landscape Dynamics: The patent landscape is highly active, with potential for opposition, challenges, or licensing negotiations influencing commercial strategies.

FAQs

1. What is the typical scope of pharmaceutical patents like AR122784 in Argentina?
Pharmaceutical patents generally cover chemical compounds, formulations, synthesis processes, and therapeutic uses. The scope depends on how broad or narrow the claims are drafted, balancing patent strength with validity challenges.

2. How does Argentine law influence pharmaceutical patent claims?
Argentina adheres to TRIPS standards but includes provisions allowing compulsory licensing and exceptions for public health, potentially narrowing the enforceability of broad claims for critical medicines.

3. Can competitors design around AR122784?
Yes, competitors may modify the chemical structure or use different formulations to avoid infringing the patent claims, especially if the claims are narrowly drafted.

4. How does patent landscape analysis benefit pharmaceutical companies in Argentina?
It helps identify patent expiration timelines, potential infringement risks, competitor patent holdings, and licensing opportunities, supporting strategic decision-making.

5. What role do claim amendments and opposition play after patent grant?
Post-grant, opponents can challenge patent validity via opposition procedures. Amendments can clarify or narrow claims, strengthening enforceability or avoiding invalidation.


References

[1] Argentine Patent Law 24,432, Law of Patents of Inventions (Official Gazette)
[2] World Intellectual Property Organization (WIPO), Patent Cooperation Treaty (PCT) system overview
[3] Argentine Patent and Trademark Office (IMPI) guidelines and official publications
[4] Global Data, "Argentina Pharmacology Patent Landscape" (2022)
[5] López, M. et al. "Patent Strategies in Argentine Pharmaceutical Sector," Journal of Intellectual Property Law, 2021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.